Abstract:Allergic diseases and asthma are heterogenous chronic inflammatory conditions with several distinct complex endotypes. Both environmental and genetic factors can influence the development and progression of allergy. Complex pathogenetic pathways observed in allergic disorders present a challenge in patient management and successful targeted treatment strategies. The increasing availability of high-throughput omics technologies, such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics allows studying biochemical systems and pathophysiological processes underlying allergic responses. Additionally, omics techniques present clinical applicability by functional identification and validation of biomarkers. Therefore, finding molecules or patterns characteristic for distinct immune-inflammatory endotypes, can subsequently influence its development, progression, and treatment. There is a great potential to further increase the effectiveness of single omics approaches by integrating them with other omics, and nonomics data. Systems biology aims to simultaneously and longitudinally understand multiple layers of a complex and multifactorial disease, such as allergy, or asthma by integrating several, separated data sets and generating a complete molecular profile of the condition. With the use of sophisticated biostatistics and machine learning techniques, these approaches provide in-depth insight into individual biological systems and will allow efficient and customized healthcare approaches, called precision medicine. In this EAACI Position Paper, the Task Force "Omics technologies in allergic research" broadly reviewed current advances and applicability of omics techniques in allergic diseases and asthma research, with a focus on methodology and data analysis, aiming to provide researchers (basic and clinical) with a desk reference in the field. The potential of omics strategies in understanding disease pathophysiology and key tools to reach unmet needs in allergy precision medicine, such as successful patients' stratification, accurate disease prognosis, and prediction of treatment efficacy and successful prevention measures are highlighted.

Omics Approaches: A Useful Tool in Asthma Precision Medicine

Omics approaches in asthma research: Challenges and opportunities

Genomic Approach to Asthma

The understanding of asthma pathogenesis in the era of precision medicine

Omics technologies in allergy and asthma research: An EAACI position paper

Asthma in the Precision Medicine Era: Biologics and Probiotics

Omics in allergy and asthma

Benchmarking omics-based prediction of asthma development in children

Unraveling the Complexity of Asthma: Insights from Omics Approaches

Personalized asthma management in pediatric patients based on treatment response

Consistent Biomarkers And Related Pathogenesis Underlying Asthma Revealed By Systems Biology Approach

Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation

Biologics in Asthma: A Molecular Perspective to Precision Medicine

Exploring the molecular mechanisms of asthma across multiple datasets

Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop

Omics methods predict the prognosis and treatment efficacy of chronic obstructive pulmonary disease

Current Understanding on Molecular Perspectives

A Comprehensive Metagenome Study Identifies Distinct Biological Pathways in Asthma Patients: An In-Silico Approach

Research Progress of Metabolomics in Asthma

From Biomarkers to Biologics

Allergic asthma biomarkers using systems approaches